Comparative effectiveness of Lopinavir/Ritonavir‐based regimens in COVID‐19-Reference-Cited by-同舟云学术

Comparative effectiveness of Lopinavir/Ritonavir‐based regimens in COVID‐19

Author:

Qu Jian¹²^ORCID,Li Guo‐Hua¹²,Wang Jiao‐Jiao¹²,He Ge‐Fei³,Huang Juan‐Juan³,Chen Ying⁴,Qu Qiang⁵,Chen Xiang‐Yu⁶,Lu Qiong¹²

Affiliation:

1. Department of Pharmacy The Second Xiangya HospitalCentral South University Changsha China

2. Institute of Clinical Pharmacy Central South University Changsha China

3. The First Hospital of Changsha Changsha China

4. Department of Pharmacy Wuhan UniversityRenmin Hospital Wuhan China

5. Department of Pharmacy The Xiangya HospitalCentral South University Changsha China

6. Department of Radiology The Second Xiangya HospitalCentral South University Changsha China

Publisher

Wiley

Subject

Physiology (medical),Pharmacology,Physiology

Link

Reference30 articles.

2. WHO.Coronavirus disease 2019 (COVID‐19) Situation Report ‐ 118. Coronavirus disease 2019 (COVID‐19) 2020. Accessed 18 May 2020.

4. Pharmacologic treatments for Coronavirus Disease 2019 (COVID‐19): a review;Sanders JM;JAMA,2020

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献